GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ATAI Life Sciences NV (NAS:ATAI) » Definitions » Price-to-Tangible-Book

ATAI (ATAI Life Sciences NV) Price-to-Tangible-Book : 3.79 (As of Jul. 10, 2025)


View and export this data going back to 2021. Start your Free Trial

What is ATAI Life Sciences NV Price-to-Tangible-Book?

As of today (2025-07-10), ATAI Life Sciences NV's share price is $2.73. ATAI Life Sciences NV's Tangible Book per Share of Mar. 2025 for the quarter that ended in Mar. 2025 was $0.72. Hence, ATAI Life Sciences NV's Price to Tangible Book Ratio of today is 3.79.

The historical rank and industry rank for ATAI Life Sciences NV's Price-to-Tangible-Book or its related term are showing as below:

ATAI' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 0.8   Med: 1.79   Max: 6.03
Current: 3.79

During the past 6 years, ATAI Life Sciences NV's highest Price to Tangible Book Ratio was 6.03. The lowest was 0.80. And the median was 1.79.

ATAI's Price-to-Tangible-Book is ranked worse than
56.96% of 1199 companies
in the Biotechnology industry
Industry Median: 3.01 vs ATAI: 3.79

A closely related ratio is called PB Ratio. As of today, ATAI Life Sciences NV's share price is $2.73. ATAI Life Sciences NV's Book Value per Sharefor the quarter that ended in Mar. 2025 was $0.76. Hence, ATAI Life Sciences NV's P/B Ratio of today is 3.59.


ATAI Life Sciences NV Price-to-Tangible-Book Historical Data

The historical data trend for ATAI Life Sciences NV's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ATAI Life Sciences NV Price-to-Tangible-Book Chart

ATAI Life Sciences NV Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Price-to-Tangible-Book
Get a 7-Day Free Trial - 3.25 1.69 0.97 1.98

ATAI Life Sciences NV Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.47 1.33 1.34 1.98 1.89

Competitive Comparison of ATAI Life Sciences NV's Price-to-Tangible-Book

For the Biotechnology subindustry, ATAI Life Sciences NV's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ATAI Life Sciences NV's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ATAI Life Sciences NV's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where ATAI Life Sciences NV's Price-to-Tangible-Book falls into.


;
;

ATAI Life Sciences NV Price-to-Tangible-Book Calculation

ATAI Life Sciences NV's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Mar. 2025 )
=2.73/0.72
=3.79

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


ATAI Life Sciences NV Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of ATAI Life Sciences NV's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


ATAI Life Sciences NV Business Description

Traded in Other Exchanges
Address
Wallstrasse 16, Berlin, BB, DEU, 10179
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company on a mission to develop effective mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 (buccal film DMT) for treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder. It is also advancing a drug discovery program to identify novel, non-hallucinogenic 5-HT2AR agonists for TRD.
Executives
Apeiron Investment Group Ltd. 10 percent owner BLOCK A, APT.12, IL-PIAZZETTA, TOWER ROAD, SLIEMA O1 SLM1605
Srinivas Rao officer: See Remarks C/O ATAI LIFE SCIENCES N.V., 180 VARICK STREET, NEW YORK NY 10014
Sahil Kirpekar officer: Chief Business Officer C/O ATAI LIFE SCIENCES N.V., WALLSTRASSE 16, BERLIN 2M 10179
Anne Nagengast Johnson officer: Chief Accounting Officer C/O ATAI LIFE SCIENCES N.V., WALLSTRASSE 16, BERLIN 2M 10179
Florian Brand officer: See Remarks C/O ATAI LIFE SCIENCES N.V., 180 VARICK STREET, NEW YORK NY 10014
Stephen Bardin officer: Chief Financial Officer C/O ATAI LIFE SCIENCES N.V., KRAUSENSTRASSE 9-10, BERLIN 2M 10117
Gregory L Weaver officer: Chief Financial Officer 185 BERRY STREET, SUITE 6504, SAN FRANCISCO CA 94107
Andrea Heslin Smiley director 600 LEE ROAD, SUITE 100, WAYNE PA 19087
Michael Auerbach director 158 HESTER STREET, APT 7F, NEW YORK NY 10013
Amir H Kalali director 4350 EXECUTIVE DRIVE SUITE 325, SAN DIEGO CA 92121
Christian Angermayer director, 10 percent owner BLOCK A, APT.12, IL-PIAZZETTA, TOWER ROAD, SLIEMA O1 SLM1605
Rosnay Alexis De director C/O ATAI LIFE SCIENCES N.V., 180 VARICK STREET, NEW YORK NY 10014
Sabrina Martucci Johnson director 11119 NORTH TORREY PINES ROAD, SUITE 200, LA JOLLA CA 92037
Jason Camm director C/O ATAI LIFE SCIENCES N.V., 180 VARICK STREET, NEW YORK NY 10014
Presight Ii, Lp 10 percent owner C/O ATAI LIFE SCIENCES N.V., 180 VARICK STREET, NEW YORK NY 10014